Sourcing & Quality Policy

This policy explains how EVLV approaches supplier confidentiality, analytical verification, batch documentation and quality review for the research-use-only compounds we supply. Our aim is to be clear about what we verify, what we document, and why we don't publish specific supplier identities or sourcing locations.

We evaluate products on testing, documentation, batch integrity and release standards — not marketing claims tied to a country of origin.

EVLV works with vetted manufacturing and supply partners to keep research compounds consistently available. Products may move through different supply channels depending on availability, production schedules, inventory planning and quality requirements.

We don't represent a product as better or worse based on geographic origin alone. Instead, we focus on standards we can actually verify:

• Analytical verification
• Batch-specific records
• Controlled release review
• Label and lot integrity
• Internal inspection standards
• Research identification

EVLV works with a network of vetted manufacturing and supply partners. Consistent with standard practice across pharmaceutical, research, specialty-chemical and laboratory-supply chains, we don't publish specific manufacturers, laboratories, supplier names, production facilities or sourcing locations.

Keeping supplier details confidential protects supply-chain integrity, supports long-term quality partnerships, reduces disruption risk, and helps us keep quality consistent from batch to batch.

Confidentiality doesn't replace verification — we still use analytical documentation and batch review to decide what actually ships.

Every product goes through quality review before release. Where applicable, we use independent third-party analytical testing to verify identity, purity and related quality attributes against our internal benchmarks.

That review can include analytical documentation, batch inspection, label verification, lot tracking, and comparison against our internal acceptance standards. Every product meets these requirements before distribution, regardless of supplier or region.

EVLV supports batch-level documentation and traceability for everything we release. That can include:

COAs and testing records support research identification and quality review. They are not medical, therapeutic, diagnostic or regulatory approvals. See our COA archive for published batch reports.

Depending on availability, production requirements and supply-chain conditions, products may be sourced from more than one region. We don't treat region of origin as a proxy for quality — every product goes through the same internal quality expectations, documentation standards and analytical review regardless of where it was sourced.

Testing, batch integrity, documentation and release review are our standard. Supplier location isn't.

Everything EVLV supplies is intended strictly for research and laboratory use. Products are not intended for human consumption, veterinary use, diagnosis, treatment, mitigation, cure or prevention of disease, and we don't market them as finished pharmaceuticals, dietary supplements, food ingredients, cosmetics, medical treatments or veterinary products.

Full detail on what our team can and can't discuss lives in our Research Use Only policy.

You can reach out about analytical testing, batch documentation, COA access, lot verification and other quality documentation covered by this policy. We'll provide what we can within appropriate confidentiality, compliance and operational limits.

We may decline requests seeking confidential supplier details, protected business information, proprietary documentation, or anything outside the scope of research-use-only product support.

EVLV doesn't disclose confidential supplier, manufacturer, laboratory, logistics, procurement or sourcing-location information, except where required by law, regulation, court order, valid legal process, or an authorized compliance review.

Nothing in this policy guarantees uninterrupted supply, identical sourcing for every batch, or disclosure of proprietary business relationships.

We may update this policy at any time to reflect operational changes, supply-chain developments, documentation practices, quality standards or compliance requirements. The most current version is always the one published on this page.